These results support the low-grade systemic inflammation connected with obesity [40], considering obese patients showed increased levels of plasmatic IL-6 and IL-1β, inducing a higher risk of β-cell dysfunction and T2DM [41]. The gene discussed is IL1B; the disease is obesity disorder.